230 related articles for article (PubMed ID: 8807143)
21. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
Christensen JG; Goldsworthy TL; Cattley RC
Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
[TBL] [Abstract][Full Text] [Related]
22. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
[TBL] [Abstract][Full Text] [Related]
23. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
[TBL] [Abstract][Full Text] [Related]
24. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
25. Carcinogenicity and mutagenicity of heterocyclic amines in transgenic mouse models.
Thorgeirsson SS; Ryu DY; Weidner V; Snyderwine EG
Cancer Lett; 1999 Sep; 143(2):245-7. PubMed ID: 10503912
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
27. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
Tamano S; Merlino GT; Ward JM
Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte growth factor in transgenic mice.
Shiota G; Kawasaki H
Int J Exp Pathol; 1998 Oct; 79(5):267-77. PubMed ID: 10193310
[TBL] [Abstract][Full Text] [Related]
29. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
Kao CY; Factor VM; Thorgeirsson SS
Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
Factor VM; Jensen MR; Thorgeirsson SS
Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
[TBL] [Abstract][Full Text] [Related]
31. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
[TBL] [Abstract][Full Text] [Related]
32. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
[TBL] [Abstract][Full Text] [Related]
33. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.
Sargent LM; Zhou X; Keck CL; Sanderson ND; Zimonjic DB; Popescu NC; Thorgeirsson SS
Am J Pathol; 1999 Apr; 154(4):1047-55. PubMed ID: 10233843
[TBL] [Abstract][Full Text] [Related]
34. Minimal cooperation between mutant Hras and c-myc or TGFα in the regulation of mouse hepatocyte growth or transformation in vivo.
Stein TJ; Bowden M; Sandgren EP
Liver Int; 2011 Oct; 31(9):1298-305. PubMed ID: 22093452
[TBL] [Abstract][Full Text] [Related]
35. Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.
Factor V; Oliver AL; Panta GR; Thorgeirsson SS; Sonenshein GE; Arsura M
Hepatology; 2001 Jul; 34(1):32-41. PubMed ID: 11431731
[TBL] [Abstract][Full Text] [Related]
36. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
[TBL] [Abstract][Full Text] [Related]
38. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice.
Webber EM; Wu JC; Wang L; Merlino G; Fausto N
Am J Pathol; 1994 Aug; 145(2):398-408. PubMed ID: 8053497
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the cooperative effects of transforming growth factor alpha and c-myc overexpression in rat liver epithelial cells.
Presnell SC; Thompson MT; Strom SC
Mol Carcinog; 1995 Aug; 13(4):233-44. PubMed ID: 7646762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]